Exosome
CD31
Antibodies Panel
IR167-643 anti-PD-L1 antibody IHC image IR167-643 anti-PD-L1 antibody IHC image IR167-643 anti-PD-L1 antibody IHC image IR167-643 anti-PD-L1 antibody ICC/IF image
+1
Catalog Number:IR167-643

PD-L1 / CD274 C terminal antibody (IHC prefer)

Application
  • WB
  • IF
  • IHC
Reactivity Hu

Product Includes

-

Application Dilution

Western Blot & Immunoprecipitation: Reported in the literature, not verified in house.
Immunofluorescence 1:100-1:300
Immunohistochemistry (Paraffin) 1:100-1:250

Storage

Store at +4°C for short term storage. Long time storage is recommended at -20°C
100mM Tris Glycine, 50% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative

Specificity / Sensitivity

Endogenous

Source / Immunogen

Synthetic peptide / Intracellular domain corresponding to Human PD-L1 / CD274

This gene encodes an immune inhibitory receptor ligand that is expressed by hematopoietic and non-hematopoietic cells, such as T cells and B cells and various types of tumor cells. The encoded protein is a type I transmembrane protein that has immunoglobulin V-like and C-like domains. Interaction of this ligand with its receptor inhibits T-cell activation and cytokine production. During infection or inflammation of normal tissue, this interaction is important for preventing autoimmunity by maintaining homeostasis of the immune response. In tumor microenvironments, this interaction provides an immune escape for tumor cells through cytotoxic T-cell inactivation. Expression of this gene in tumor cells is considered to be prognostic in many types of human malignancies, including colon cancer and renal cell carcinoma. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2015]

Title
No data.

Reviews

Please login before enter the comment!